Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Health Literacy Project is a clinical trial that aims to improve understanding and attitudes about epilepsy among teenagers. The study will provide educational sessions to help adolescents, aged 12 to 18, learn more about their condition and how to manage it. Researchers want to see if better knowledge and attitudes can lead to teens taking their medications more regularly and feeling less stigma about their epilepsy.
To be part of this study, participants need to be diagnosed with epilepsy and be able to communicate in English, Runyankole, or Luganda. They also need permission from a parent or guardian. The study is not recruiting participants yet, but once it starts, eligible teens can expect to engage in educational activities and share their thoughts through surveys that will help researchers understand how the intervention affects their knowledge and experiences with epilepsy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adolescents with a diagnosis of epilepsy attending a clinic at one of the study sites.
- • Ages 12-18 years
- • Ability and willingness to provide informed assent and guardian consent to participate in the study.
- • English, Runyankole or Luganda language proficiency.
- Exclusion Criteria:
- • Unable or unwilling to provide informed consent or assent to participate in the study.
- • Developmental/cognitive challenges that hinder participation in the intervention or completion of surveys.
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mbarara, , Uganda
Mbarara, , Uganda
Patients applied
Trial Officials
Deborah Koltai, MD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported